In the BioHarmony Drug Report Database

"Preview" Icon

Mycophenolate mofetil

Cellcept, CellCept (mycophenolate mofetil) is a small molecule pharmaceutical. Mycophenolate mofetil was first approved as Cellcept on 1995-05-03. It is used to treat graft vs host disease and psoriasis in the USA. It has been approved in Europe to treat graft rejection. The pharmaceutical is active against inosine-5′-monophosphate dehydrogenase 2 and inosine-5′-monophosphate dehydrogenase 1.

 

Trade Name

 

CellCept
 

Common Name

 

mycophenolate mofetil
 

ChEMBL ID

 

CHEMBL1456
 

Indication

 

graft rejection, graft vs host disease, psoriasis
 

Drug Class

 

Image (chem structure or protein)

Mycophenolate mofetil structure rendering